Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem

Author(s): Vladlena I. Zozina*, Serghei Covantev, Olga A. Goroshko, Liudmila M. Krasnykh, Vladimir G. Kukes.

Journal Name: Current Cardiology Reviews

Volume 14 , Issue 3 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years, it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation.

Keywords: Coenzyme Q10, hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 14
ISSUE: 3
Year: 2018
Page: [164 - 174]
Pages: 11
DOI: 10.2174/1573403X14666180416115428
Price: $58

Article Metrics

PDF: 37
HTML: 2